Taken together, these results indicate that HNRNPC inhibition not only arrests HCC cells in G0/G1 phase to inhibit tumor proliferation, but also suppresses EMT process to block invasion and migration of HCC cells in part via the Ras/Raf/MEk/Erk signaling pathway. Here, MAP2K7 is linked to hepatocellular carcinoma.